Journal
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
Volume 29, Issue 2, Pages 275-+Publisher
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/S0889-857X(03)00021-8
Keywords
-
Categories
Funding
- NIAMS NIH HHS [AR46126] Funding Source: Medline
Ask authors/readers for more resources
The scleroderma (SSc) disease process involves dramatic dysfunction in acute and chronic vascular regulatory mechanisms; it presents initially with heightened vasoconstrictor or vasospastic activity and progresses to structural derangement or vasculopathy of the microcirculation. This article discusses the regulatory mechanisms that contribute to this dysfunction and the vascular changes in the context of the other aspects of the SSc disease process in a novel attempt to integrate the individual pathologies of the disease process.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available